ARBS: Revenue up 7% year-over-year to €2.8 million, with strong growth in cosmetic raw materials

About this update from Arterra Bioscience Spa

Revenue rose 7% year-over-year to €2.8 million as of September 30, 2024, driven by growth in cosmetic raw materials and services. Management is optimistic for the full year, supported by a strong order backlog.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Arterra Bioscience Spa